Levels of ARV in blood reflect recent exposure (hours to days), but the outcomes of cART are based on exposure over months. We hypothesized that levels of efavirenz (EFV) in hair, which reflects exposure occurring over several weeks would better predict virologic response than single blood levels.
Intensive PK (iPK), sparse blood and hair samples (1 cm of scalp) were collected from participants of the Women’s Interagency HIV Study who reported current use of EFV. EFV levels were measured in blood and hair by validated liquid chromatography tandem mass spec method. Population PK models were developed including clinical covariates previously shown to influence exposure (area under the curve, AUC). AUC was estimated from sparse blood levels and time of last dose using NONMEM methods and compared directly to level in hair (also an indicator of exposure) using random effects multivariate logistic regression.
AUC by iPK was typically about 50% greater than that estimated from sparse sample, though the values were correlated (median ratio of AUC by iPK to AUC by sparse = 1.47, correlation coef =0.83, p<.0001, n=92). When AUC estimated from sparse blood samples were compared to levels measured in hair as predictors of virologic suppression (in models of 1071 observations made of 315 individuals that adjusted for adherence, decade of age, ethnicity and individual) log level in hair was a statistically significant predictor of suppression, while AUC estimated from sparse samples was not (Table below).
Exposure to EFV estimated from hair samples better predicted virologic response than exposure estimated from single blood specimens and time since dose. These findings support the utility of measures of long term exposure in predicting treatment responses, which may be important for research and in the management of patients who are at high risk for treatment failure.